pv-pinpoint: a study investigating the diagnosis and management of polycythemia vera in the uk
Published 2 months ago • 91 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:12
contemporary challenges in polycythemia vera management
-
1:30
the patient perspective of polycythemia vera and second-line treatment options
-
2:55
pv-aim: using machine learning to predict resistance to hydroxyurea therapy in patients with pv
-
6:04
the need to improve diagnostic criteria in pv and other challenges in the field
-
2:54
an update on the use of idasanutlin in polycythemia vera
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
3:39
the treatment of low and high-risk polycythemia vera
-
6:31
the current treatment landscape for polycythemia vera
-
2:14
risk-adapted treatment of et & pv
-
1:39
upcoming agents in et and pv
-
1:34
are thrombotic risk and progression in et predictable?
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
1:35
novel mutations in pv & the importance of understanding their role in disease initiation
-
19:56
i have polycythemia vera (pv) | how i found out, treatment, and next steps
-
0:48
highlights from mpn sessions
-
15:03
hematology in 10 min: polycythemia
-
2:16
ropeginterferon vs standard therapy for polycythemia vera
-
2:00
the role of fedratinib in 2024 and beyond
-
3:15
updates on ropeginterferon in pv
-
3:05
recent updates in the mpn field: clinical trials, novel agents, and more
-
1:30
the verify trial: rusfertide in patients with polycythemia vera
-
5:50
machine-learning to predict hydroxyurea failure & thromboembolic events in polycythemia vera